ID   N9
AC   CVCL_0452
SY   N-9
DR   BTO; BTO_0003957
DR   MCCL; MCC:0000349
DR   ChEMBL-Cells; CHEMBL4483172
DR   ChEMBL-Targets; CHEMBL4483281
DR   Lonza; 1424
DR   PubChem_Cell_line; CVCL_0452
DR   Wikidata; Q54907352
RX   PubMed=7681038;
RX   PubMed=21961028;
RX   PubMed=22651808;
CC   Transformant: Recombinant retrovirus 3RV/VN-11.
CC   Derived from site: In situ; Embryonic brain; UBERON=UBERON_0006238.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   13FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
RX   PubMed=7681038; DOI=10.1002/glia.440070309;
RA   Corradin S.B., Mauel J., Donini S.D., Quattrocchi E.,
RA   Ricciardi-Castagnoli P.;
RT   "Inducible nitric oxide synthase activity of cloned murine microglial
RT   cells.";
RL   Glia 7:255-262(1993).
//
RX   PubMed=21961028; DOI=10.2174/1877381801002010148; PMCID=PMC3180920;
RA   Crain J.M., Watters J.J.;
RT   "Estrogen and P2 purinergic receptor systems in microglia: therapeutic
RT   targets for neuroprotection.";
RL   Open Drug Discov. J. 2:148-167(2010).
//
RX   PubMed=22651808; DOI=10.1186/1742-2094-9-115; PMCID=PMC3407712;
RA   Stansley B., Post J., Hensley K.;
RT   "A comparative review of cell culture systems for the study of
RT   microglial biology in Alzheimer's disease.";
RL   J. Neuroinflammation 9:115.1-115.8(2012).
//